Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

A. Schram; M. Borad; V. Sahai; S. Kamath; R. Kim; C. Y.A. Liao; D. Y. Oh; M. Ponz-Sarvisé; J. Yachnin; S. A. Shell; P. Cassier; E. Dotan; V. Florou; V. Moreno; J. O. Park; D. Tai; O. Schmidt-Kittler; C. Ferté; L. Goyal; V. Subbiah

doi:10.1016/S0959-8049(22)01110-8

Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

A. Schram
, M. Borad
, V. Sahai
, S. Kamath
, R. Kim
, C. Y.A. Liao
, D. Y. Oh
, M. Ponz-Sarvisé
, J. Yachnin
, S. A. Shell
, P. Cassier
, E. Dotan
, V. Florou
, V. Moreno
, J. O. Park
, D. Tai
, O. Schmidt-Kittler
, C. Ferté
, L. Goyal
, V. Subbiah

Memorial Sloan-Kettering Cancer Center
Mayo Clinic Arizona
University of Michigan, Ann Arbor
Cleveland Clinic Foundation
University of South Florida
University of Chicago
Seoul National University
University of Navarra
Karolinska Institutet
Palo Alto
Centre Léon Bérard
University of Utah
Hospital Universitario Puerta de Hierro Majadahonda
Sungkyunkwan University
National Cancer Centre
Massachusetts General Hospital
University of Texas MD Anderson Cancer Center
Relay Therapeutics

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	S116
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)01110-8
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0959-8049(22)01110-8

Cite this

Schram, A., Borad, M., Sahai, V., Kamath, S., Kim, R., Liao, C. Y. A., Oh, D. Y., Ponz-Sarvisé, M., Yachnin, J., Shell, S. A., Cassier, P., Dotan, E., Florou, V., Moreno, V., Park, J. O., Tai, D., Schmidt-Kittler, O., Ferté, C., Goyal, L., & Subbiah, V. (2022). Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor. European Journal of Cancer, 174, S116. https://doi.org/10.1016/S0959-8049(22)01110-8

@article{6d9baa0136674fd2ab0c51a53d1ca17c,

title = "Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor",

author = "A. Schram and M. Borad and V. Sahai and S. Kamath and R. Kim and Liao, \{C. Y.A.\} and Oh, \{D. Y.\} and M. Ponz-Sarvis{\'e} and J. Yachnin and Shell, \{S. A.\} and P. Cassier and E. Dotan and V. Florou and V. Moreno and Park, \{J. O.\} and D. Tai and O. Schmidt-Kittler and C. Fert{\'e} and L. Goyal and V. Subbiah",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)01110-8",

language = "English",

volume = "174",

pages = "S116",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Schram, A, Borad, M, Sahai, V, Kamath, S, Kim, R, Liao, CYA, Oh, DY, Ponz-Sarvisé, M, Yachnin, J, Shell, SA, Cassier, P, Dotan, E, Florou, V, Moreno, V, Park, JO, Tai, D, Schmidt-Kittler, O, Ferté, C, Goyal, L & Subbiah, V 2022, 'Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor', European Journal of Cancer, vol. 174, pp. S116. https://doi.org/10.1016/S0959-8049(22)01110-8

TY - JOUR

T1 - Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

AU - Schram, A.

AU - Borad, M.

AU - Sahai, V.

AU - Kamath, S.

AU - Kim, R.

AU - Liao, C. Y.A.

AU - Oh, D. Y.

AU - Ponz-Sarvisé, M.

AU - Yachnin, J.

AU - Shell, S. A.

AU - Cassier, P.

AU - Dotan, E.

AU - Florou, V.

AU - Moreno, V.

AU - Park, J. O.

AU - Tai, D.

AU - Schmidt-Kittler, O.

AU - Ferté, C.

AU - Goyal, L.

AU - Subbiah, V.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85140454096

U2 - 10.1016/S0959-8049(22)01110-8

DO - 10.1016/S0959-8049(22)01110-8

M3 - Article

AN - SCOPUS:85140454096

SN - 0959-8049

VL - 174

SP - S116

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this